Recently 2 QSPR-based in silico models were developed in our laboratories to predict the aqueous and non-aqueous solubility of drug-like organic compounds. For the intrinsic aqueous solubility model, a set of 321 structurally diverse drugs was collected from literature for the analysis. For the PEG 400 cosolvent model, experimental data for 122 drugs were obtained by a uniform experimental procedure at 4 volume fractions of PEG 400 in water, 0%, 25%, 50%, and 75%. The drugs used in both models represent a wide range of compounds, with log P values from -5 to 7.5, and molecular weights from 100 to >600 g/mol. Because of the standardized procedure used to collect the cosolvent data and the careful assessment of quality used in obtaining literature data, both data sets have potential value for the scientific community for use in building various models that require experimental solubility data.
INTRODUCTION
With increasing pressure to identify high-quality drug candidates, it is critical to assess the Absorption, Distribution, Metabolism, Excretion (ADME) attributes of compounds early on during drug discovery. This may include properties such as aqueous solubility, permeability, metabolic stability, and in vivo pharmacokinetics. One of the properties crucial to candidate screening is the solubility of the compound. When the aqueous solubility of a drug candidate is inadequate to permit solution formulations, cosolvents are often employed to improve solubility. 1 When drugs are insoluble in water, polyethylene glycol (PEG) is an excipient of choice based on its good solubilization properties and overall acceptability in terms of side-effect profile. 2 Although the literature presents several models for predicting solubilization, many require the collection of experimental data, a luxury often not afforded at this stage in drug discovery where compound is in short supply. Therefore, in silico models that can predict solubility without expending compound are of great value to the pharmaceutical scientist. Nevertheless, models can fail or result in little value if the data used to generate the model are of poor quality or were obtained under varied experimental conditions. 3 We have received numerous requests for the raw data used to generate two Quantitative Structure Property Relationship (QSPR)-based in silico models for predicting both aqueous and cosolvent solubility in our laboratories. 4, 5 For the aqueous solubility model, a set of 321 structurally diverse drugs, with their intrinsic aqueous solubility, was collected from literature and used in the analysis. For the PEG 400 cosolvent model, experimental data for 122 drugs were collected by a uniform experimental procedure at 4 volume fractions of PEG 400: 0% (aqueous), 25%, 50%, and 75%. The drugs used in both models represent a wide range of compounds, with log P values from -5 to 7.5, and molecular weights from 100 to >600 g/mol. Because of the standardized procedure used to collect the cosolvent data and the careful assessment of quality used in obtaining the literature data, both data sets have potential value for the scientific community for use in building various models that require experimental solubility data.
MATERIALS AND METHODS

Data Set Selection for the Aqueous Model
The solubility values of 321 compounds (listed in Table 1) were obtained from the Analytical Profile of Drug 
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